Is it possible to phenotype patients in Osteoarthritis?
WCO-IOF-ESCEO, MILAN 2015
Critical evaluation of promising markers for sarcopenia
en
Prof. Etienne Cavalier
Main topics of the 15th WCO-IOF-ESCEO Congress
en
Prof. Jean-Y. Reginster
Phase 2 trial of myostatin antibody in weak older fallers
en
Prof. Serge Ferrari
Calcium plus vitamin D supplementation and cardiovascular safety
en
Prof. John A. Kanis
Vitamin D levels, calcium nutrition and risk of fracture
en
Prof. Cyrus Cooper
Repeated loading influences cortical bone geometry and strength
en
Dr. Emmanuel Biver
Nutritional management of osteoporotic patients
en
Prof. René Rizzoli
Osteoporosis therapy in high risk residents living in l.t. care homes
en
Dr. George Ioannidis
Blocking bone breakdown and stimulating new bone
en
Prof. Silvano Adami
Bloccare la distruzione dell'osso stimolando la neoformazione
it
Prof. Silvano Adami
Fracture risk prediction and its interaction with FRAX
en
Dr. Bill Leslie
How to control osteoporosis bone pain
it
Prof. Maria Luisa Brandi
Cost effectiveness evaluation of fracture liaison services, in Sweden - Emma Jonsson, BSc
en
Sclerostin inhibition for severe osteoporosis
en
Prof. Socrates Papapoulos
Hyaluronic acid salts in the management of osteoarthritis in Europe
en
Prof. Jean-P. Pelletier